232 related articles for article (PubMed ID: 8439675)
1. Wearable artificial kidneys for continuous dialysis. A personal view.
Roberts M
ASAIO J; 1993; 39(1):19-23. PubMed ID: 8439675
[TBL] [Abstract][Full Text] [Related]
2. Problems and solutions for artificial kidney.
Vanholder R
Technol Health Care; 2000; 8(6):373-9. PubMed ID: 11258583
[TBL] [Abstract][Full Text] [Related]
3. The Vicenza wearable artificial kidney for peritoneal dialysis (ViWAK PD).
Ronco C; Fecondini L
Blood Purif; 2007; 25(4):383-8. PubMed ID: 17785968
[TBL] [Abstract][Full Text] [Related]
4. A Proposed Peritoneal-Based Wearable Artificial Kidney.
Roberts M; Lee DBN
Home Hemodial Int; 1999 Jan; 3(1):65-67. PubMed ID: 28455868
[TBL] [Abstract][Full Text] [Related]
5. A peritoneal-based automated wearable artificial kidney.
Lee DB; Roberts M
Clin Exp Nephrol; 2008 Jun; 12(3):171-80. PubMed ID: 18386116
[TBL] [Abstract][Full Text] [Related]
6. [Continuous ambulatory peritoneal dialysis in diabetic patients].
Stojimrović B; Nesić V
Srp Arh Celok Lek; 1998; 126(7-8):277-82. PubMed ID: 9863395
[TBL] [Abstract][Full Text] [Related]
7. A continuous hemofiltration system using sorbents for hemofiltrate regeneration.
Murisasco A; Baz M; Boobes Y; Bertocchio P; el Mehdi M; Durand C; Reynier JP; Ragon A
Clin Nephrol; 1986; 26 Suppl 1():S53-7. PubMed ID: 3829469
[TBL] [Abstract][Full Text] [Related]
8. Innovative peritoneal dialysis: flow-thru and dialysate regeneration.
Roberts M; Ash SR; Lee DB
ASAIO J; 1999; 45(5):372-8. PubMed ID: 10503611
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal changes of peritoneal function calculated by personal dialysis capacity in a patient after long-term continuous ambulatory peritoneal dialysis.
Nakamoto H; Takane H; Sugahara S; Kanno Y; Okada H; Yamamoto T; Suzuki H
Adv Perit Dial; 2003; 19():97-102. PubMed ID: 14763042
[TBL] [Abstract][Full Text] [Related]
10. The future of the artificial kidney: moving towards wearable and miniaturized devices.
Ronco C; Davenport A; Gura V
Nefrologia; 2011; 31(1):9-16. PubMed ID: 21270908
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up of body size indices, residual renal function, and peritoneal transport characteristics in continuous ambulatory peritoneal dialysis.
Twardowski ZJ; Moore HL; Prowant BF; Satalowich R
Adv Perit Dial; 2009; 25():155-64. PubMed ID: 19886338
[TBL] [Abstract][Full Text] [Related]
12. Treatment with the artificial kidney (dialysis).
Farrell PC; Stewart JH
Med J Aust; 1976 Feb; 1(6):160-5. PubMed ID: 1263970
[TBL] [Abstract][Full Text] [Related]
13. Residual renal function in children treated with continuous ambulatory peritoneal dialysis or automated peritoneal dialysis--a preliminary study.
Roszkowska-Blaim M; Skrzypczyk P; Drozdz D; Pietrzyk JA
Adv Perit Dial; 2009; 25():103-9. PubMed ID: 19886329
[TBL] [Abstract][Full Text] [Related]
14. Adequacy in dialysis: intermittent versus continuous therapies.
Misra M; Nolph KD
Nefrologia; 2000; 20 Suppl 3():25-32. PubMed ID: 10835874
[TBL] [Abstract][Full Text] [Related]
15. [The effect of hemodialysis and continuous ambulatory peritoneal dialysis on renal anemia].
Stojimirović B; Grujić-Adanja G
Srp Arh Celok Lek; 1997; 125(5-6):163-7. PubMed ID: 9265238
[TBL] [Abstract][Full Text] [Related]
16. Peritoneal rest may successfully recover ultrafiltration in patients who develop peritoneal hyperpermeability with time on continuous ambulatory peritoneal dialysis.
Rodrigues A; Cabrita A; Maia P; Guimarães S
Adv Perit Dial; 2002; 18():78-80. PubMed ID: 12402593
[TBL] [Abstract][Full Text] [Related]
17. Peritoneal dialysis is the therapy of choice for end-stage renal disease patients with hereditary clotting disorders.
Bajo MA; del Peso G; Jiménez V; Aguilera A; Villar A; Jiménez C; Selgas R
Adv Perit Dial; 2000; 16():170-3. PubMed ID: 11045286
[TBL] [Abstract][Full Text] [Related]
18. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients.
Sezer S; Tutal E; Arat Z; Akçay A; Celik H; Ozdemir FN; Haberal M
J Ren Nutr; 2005 Oct; 15(4):427-34. PubMed ID: 16198934
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor-alpha during continuous high-flux hemodialysis in sepsis with acute renal failure.
Lonnemann G; Bechstein M; Linnenweber S; Burg M; Koch KM
Kidney Int Suppl; 1999 Nov; (72):S84-7. PubMed ID: 10560813
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis.
Choi KC; Jeong TK; Lee SC; Kim SW; Kim NH; Lee KY
Adv Perit Dial; 1998; 14():173-9. PubMed ID: 10649719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
